DUBLIN--(BUSINESS WIRE)--The "US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)" report has been added to ...
In order to determine the risk of PD associated with various β2‐adrenoreceptor drugs, the study authors assessed United States Medicare beneficiary data from 2009. Neither β2‐adrenoreceptor agonists ...
Velicept Therapeutics announced that solabegron met the primary endpoint in the phase 2b VEL-2002 study that evaluated patients with overactive bladder (OAB). Velicept Therapeutics announced that ...
Alpha₂ agonists are commonly used in combination with other anesthetic agents to chemically immobilize wildlife and may cause potentially serious hypoxemia in wild ruminants. In some domestic ...
Atherosclerosis. Computer artwork of a narrowed artery, due to a cholesterol plaque. A drug that is commonly used to treat overactive bladder could be putting some patients at increased risk of ...
Velicept Therapeutics announced that solabegron met the primary endpoint in the phase 2b VEL-2002 study that evaluated patients with overactive bladder (OAB). Velicept Therapeutics announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback